Detection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies
Data up to Jan 2025
Total Citations Per Year
Abstract
References (65)
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
1970 • 253,849 citations
The 1982 revised criteria for the classification of systemic lupus erythematosus
1982 • 14,553 citations
Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIA
1973 • 6,904 citations
The Role of Polyamines in the Neutralization of Bacteriophage Deoxyribonucleic Acid
1960 • 2,598 citations
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
1990 • 1,618 citations
ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
1983 • 1,413 citations
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
1990 • 1,294 citations
Antibody to Cardiolipin as a Predictor of Fetal Distress or Death in Pregnant Patients with Systemic Lupus Erythematosus
1985 • 594 citations
Obstetric Complications Associated with the Lupus Anticoagulant
1985 • 568 citations
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
1985 • 554 citations
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
1986 • 554 citations
THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.
1963 • 524 citations
Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.
1983 • 518 citations
Thrombosis in Patients with the Lupus Anticoagulant
1980 • 511 citations
A clinical study of the lupus anticoagulant
1976 • 478 citations
Complement Proteins C5b-9 Induce Secretion of High Molecular Weight Multimers of Endothelial von Willebrand Factor and Translocation of Granule Membrane Protein GMP-140 to the Cell Surface
1989 • 442 citations
FETAL SURVIVAL AFTER PREDNISONE SUPPRESSION OF MATERNAL LUPUS-ANTICOAGULANT
1983 • 427 citations
Confidence Intervals for Reporting Results of Clinical Trials
1986 • 425 citations
Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
1980 • 367 citations
Primary Antiphospholipid Syndrome
2020 • 354 citations
Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant
1984 • 312 citations
Prothrombinase activity of human platelets is inhibited by β2-glycoprotein-I
1986 • 308 citations
“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation
1982 • 300 citations
Circulating anticoagulants: a study of 40 cases and a review of the literature.
1961 • 285 citations
Laboratory Diagnosis of Lupus Inhibitors: A Comparison of the Tissue Thromboplastin Inhibition Procedure with a New Platelet Neutralization Procedure
1983 • 285 citations
Anti-prothrombin antibodies and the lupus anticoagulant
1988 • 255 citations
Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
1984 • 253 citations
Natural anticoagulant mechanisms.
1984 • 251 citations
Anticardiolipin response in acute infections
1986 • 235 citations
Lupus anticoagulant in pregnancy
1984 • 224 citations
CIRCULATING ANTICOAGULANTS
1961 • 223 citations
Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage.
1979 • 218 citations
β2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation
1987 • 200 citations
Effect of Lupus Anticoagulant on Antithrombogenic Properties of Endothelial Cells - Inhibition of Thrombomodulin-Dependent Protein C Activation
1988 • 194 citations
Thrombosis in Systemic Lupus Erythematosus
1985 • 191 citations
Circulating Coagulation Inhibitors in the Acquired Immunodeficiency Syndrome
1986 • 187 citations
Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.
1988 • 182 citations
Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant
1989 • 178 citations
Anticardiolipin antibodies associated with HTLV‐III infection
1987 • 169 citations
Biosynthesis of von Willebrand protein by human endothelial cells. Identification of a large precursor polypeptide chain.
1983 • 166 citations
Antibody and immune complexes induce tissue factor production by human endothelial cells.
1986 • 164 citations
Lupus Anticoagulant in the Acquired Immunodeficiency Syndrome
1986 • 161 citations
An IgM Lupus Anticoagulant that Neutralizes the Enhancing Effect of Phospholipid on Purified Endothelial Thrombomodulin Activity-A Mechanism for Thrombosis
1986 • 130 citations
Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.
1988 • 122 citations
Quantification of human platelet inositides and the influence of ionic environment on their incorporation of orthophosphate-32P
1971 • 117 citations
Distinguishing Plasma Lupus Anticoagulants from Anti-Factor Antibodies Using Hexagonal (II) Phase Phospholipids
1989 • 111 citations
Binding of β2-glycoprotein I to platelets: Effect of adenylate cyclase activity
1980 • 107 citations
Crossreactivity of Antibodies Directed against Cardiolipin, DNA, Endothelial Cells and Blood Platelets
1990 • 93 citations
Separation of anticardiolipin antibodies from lupus anticoagulant on a phospholipid-coated polystyrene column
1988 • 83 citations
Thrombosis Associated with Antiphospholipid Antibodies Cannot Be Explained by Effects on Endothelial and Platelet Prostanoid Synthesis
1988 • 82 citations
Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay.
1987 • 82 citations
Lupus anticoagulant induces a selective defect in thrombin‐mediated endothelial prostacyclin release and platelet aggregation
1989 • 75 citations
Lupus anticoagulant and antiplatelet properties of human hybridoma autoantibodies.
1987 • 75 citations
Impaired Fibrinolysis as an Essential Contribution to Thrombosis in Patients with Lupus Anticoagulant
1989 • 73 citations
Evidence that cell surface heparan sulfate is involved in the high affinity thrombin binding to cultured porcine aortic endothelial cells.
1985 • 72 citations
Lupus anticoagulant inhibition of in Vitro prostacyclin release is associated with a thrombosis-prone subset of patients
1991 • 69 citations
Primary antiphospholipid syndrome
1990 • 66 citations
IgG Binding to Endothelial Cells in Systemic Lupus Erythematosus
1986 • 55 citations
Second-trimester fetal monitoring and preterm delivery in pregnancies with systemic lupus erythematosus and/or circulating anticoagulant
1987 • 52 citations
Cofactor dependent and cofactor independent anticardiolipin antibodies
1991 • 49 citations
Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus.
1987 • 48 citations
Platelet binding properties of monoclonal lupus autoantibodies produced by human hybridomas
1985 • 35 citations
Hybridoma lupus autoantibodies can bind major cytoskeletal filaments in the absence of DNA‐binding activity
1988 • 30 citations
Influence of Fusion Cell Ratio and Cell Plating Density on Production of Human-Human Hybridomas Secreting Anti-DNA Autoantibodies from Patients with Systemic Lupus Erythematosus
1984 • 29 citations
Anticardiolipin antibodies in patients with primary immunodeficiency diseases.
1988 • 7 citations